| __timestamp | Amneal Pharmaceuticals, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 2652041 |
| Thursday, January 1, 2015 | 109679000 | 2361587 |
| Friday, January 1, 2016 | 118757000 | 4472869 |
| Sunday, January 1, 2017 | 109046000 | 5030957 |
| Monday, January 1, 2018 | 230435000 | 4988941 |
| Tuesday, January 1, 2019 | 289598000 | 5196412 |
| Wednesday, January 1, 2020 | 326727000 | 6652774 |
| Friday, January 1, 2021 | 365504000 | 18418247 |
| Saturday, January 1, 2022 | 399700000 | 24827066 |
| Sunday, January 1, 2023 | 429675000 | 41896408 |
| Monday, January 1, 2024 | 15488619 |
Data in motion
In the ever-evolving pharmaceutical landscape, understanding operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Amneal Pharmaceuticals, a major player, saw its SG&A expenses grow by over 400% during this period, peaking in 2023. In contrast, Opthea Limited, a smaller entity, experienced a more modest increase, with expenses rising by approximately 1,500% by 2023. This stark difference highlights the varying scales and strategies of these companies. Notably, Amneal's expenses consistently outpaced Opthea's, reflecting its larger operational scale. However, Opthea's rapid growth in expenses suggests an aggressive expansion strategy. Missing data for 2024 indicates potential reporting delays or strategic shifts. This financial snapshot offers a window into the operational dynamics of these pharmaceutical firms.
Selling, General, and Administrative Costs: Johnson & Johnson vs Opthea Limited
Breaking Down SG&A Expenses: Amgen Inc. vs Opthea Limited
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Opthea Limited
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Opthea Limited
Halozyme Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Opthea Limited vs Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Opthea Limited and Amicus Therapeutics, Inc.
Opthea Limited or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Amneal Pharmaceuticals, Inc. or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Perrigo Company plc